As of June 30, 2025, the Company had cash and cash equivalents and short-term deposits in the amount of $29.5 million, compared to $15.6 million on December 31, 2024. PolyPid (PYPD) expects that its current cash balance will be sufficient to fund operations well into 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements
- PolyPid appoints Tweezer-Zaks as Chief Medical Officer
- PYPD Upcoming Earnings Report: What to Expect?
- PolyPid files to sell 7.63M ordinary shares for holders
- PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market